{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:47:06Z","timestamp":1786981626378,"version":"build-2736575974"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T00:00:00Z","timestamp":1718755200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T00:00:00Z","timestamp":1718755200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Pharm"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1007\/s11096-024-01765-3","type":"journal-article","created":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T10:02:17Z","timestamp":1718791337000},"page":"1237-1242","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Building an effective medicines optimisation model: a health system approach"],"prefix":"10.1007","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1051-3240","authenticated-orcid":false,"given":"Zaheer-Ud-Din","family":"Babar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,19]]},"reference":[{"key":"1765_CR1","unstructured":"The Nuffield Trust. Care and support for long-term conditions. 2024.https:\/\/www.nuffieldtrust.org.uk\/resource\/care-and-support-for-long-term-conditions#:~:text=In%20England%2C%20more%20than%2015,with%20medication%20or%20other%20therapies. Accessed 16 May 2024."},{"issue":"4","key":"1765_CR2","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3390\/geriatrics5040085","volume":"5","author":"P Aggarwal","year":"2020","unstructured":"Aggarwal P, Woolford SJ, Patel HP. Multi-morbidity and polypharmacy in older people: challenges and opportunities for clinical practice. Geriatrics (Basel). 2020;5(4):85. https:\/\/doi.org\/10.3390\/geriatrics5040085.","journal-title":"Geriatrics (Basel)"},{"key":"1765_CR3","unstructured":"Medicines optimisation, National Health Service. 2024https:\/\/www.england.nhs.uk\/medicines-2\/medicines-optimisation\/. Accessed 16 May 2024."},{"key":"1765_CR4","unstructured":"National Institute for Health and Clinical Excellence.\u00a0Medicines adherence: involving patients in decisions about prescribed medicines and supporting adherence. Clinical guideline CG76.\u00a0London: NICE; 2009.\u00a0http:\/\/www.nice.org.uk\/CG76\/. Accessed 16 May 2024."},{"key":"1765_CR5","unstructured":"Northern Ireland Medicines Optimisation Quality Framework. Department of Health, Social Services and Public Safety. 2016 https:\/\/www.communitypharmacyni.co.uk\/wp-content\/uploads\/2015\/05\/Medicines-Optimisation-Quality-Framework-Final-Draft.pdf. Accessed 16 May 2024."},{"key":"1765_CR6","unstructured":"Medicines optimisation: the safe and effective use of medicines to enable the best possible outcomes. 2015 https:\/\/www.nice.org.uk\/guidance\/ng5\/chapter\/introduction. Accessed 16 May 2024."},{"key":"1765_CR7","unstructured":"Medicines Optimisation: Helping patients to make the most of medicines Good practice guidance for healthcare professionals in England. Royal Pharmaceutical Society. 2013. https:\/\/www.rpharms.com\/Portals\/0\/RPS%20document%20library\/Open%20access\/Policy\/helping-patients-make-the-most-of-their-medicines.pdf. Accessed 16  May 2024."},{"issue":"6","key":"1765_CR8","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1093\/ijpp\/riad061","volume":"31","author":"M Jordan","year":"2023","unstructured":"Jordan M, Mullan J, Stewart A, et al. A pharmacist integrated into a general practice in Australia: an evolving model of care in medicines optimization. Int J Pharm Pract. 2023;31(6):608\u201316. https:\/\/doi.org\/10.1093\/ijpp\/riad061.","journal-title":"Int J Pharm Pract"},{"issue":"6","key":"1765_CR9","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1111\/bcp.12732","volume":"80","author":"E Reeve","year":"2015","unstructured":"Reeve E, Gnjidic D, Long J, et al. Systematic review of the emerging definition of \u201cdeprescribing\u201d with network analysis: implications for future research and clinical practice. Br J Clin Pharmacol. 2015;80(6):1254\u201368. https:\/\/doi.org\/10.1111\/bcp.12732.","journal-title":"Br J Clin Pharmacol"},{"key":"1765_CR10","unstructured":"National medicines optimisation opportunities 2023\/24 https:\/\/www.england.nhs.uk\/long-read\/national-medicines-optimisation-opportunities-2023-24\/. Accessed 16 May 2024."},{"issue":"7","key":"1765_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0214630","volume":"14","author":"E Graham-Clarke","year":"2019","unstructured":"Graham-Clarke E, Rushton A, Noblet T, et al. Non-medical prescribing in the United Kingdom national health service: a systematic policy review. PLoS ONE. 2019;14(7): e0214630. https:\/\/doi.org\/10.1371\/journal.pone.0214630.","journal-title":"PLoS ONE"},{"key":"1765_CR12","unstructured":"NHS England.2023 .https:\/\/www.england.nhs.uk\/primary-care\/pharmacy\/pharmacy-integration-fund\/independent-prescribing\/. Accessed 16 May 2024."},{"issue":"601","key":"1765_CR13","doi-asserted-by":"publisher","first-page":"398","DOI":"10.3399\/bjgp12X653444","volume":"62","author":"A De Simoni","year":"2012","unstructured":"De Simoni A, Mullis R, Clyne W, et al. Medicines optimisation in primary care: Can community pharmacies deliver? Br J Gen Pract. 2012;62(601):398\u20139. https:\/\/doi.org\/10.3399\/bjgp12X653444.","journal-title":"Br J Gen Pract"},{"issue":"8","key":"1765_CR14","doi-asserted-by":"publisher","first-page":"3338","DOI":"10.1016\/j.sapharm.2021.12.003","volume":"18","author":"S Costa","year":"2022","unstructured":"Costa S, Rom\u00e3o M, Mendes M, et al. Pharmacy interventions on COVID-19 in Europe: mapping current practices and a scoping review. Res Social Adm Pharm. 2022;18(8):3338\u201349. https:\/\/doi.org\/10.1016\/j.sapharm.2021.12.003.","journal-title":"Res Social Adm Pharm"},{"issue":"2","key":"1765_CR15","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s11096-023-01550-8","volume":"45","author":"F Fernandez-Llimos","year":"2023","unstructured":"Fernandez-Llimos F, Desselle S, Stewart D, et al. Improving the quality of publications in and advancing the paradigms of clinical and social pharmacy practice research: the Granada statements. Int J Clin Pharm. 2023;45(2):285\u201392. https:\/\/doi.org\/10.1007\/s11096-023-01550-8.","journal-title":"Int J Clin Pharm"},{"key":"1765_CR16","unstructured":"Pharmacy practice research special interest group.\u00a0https:\/\/www.fip.org\/pharmacy-practice-research. Accessed 16 May 2024."},{"issue":"5","key":"1765_CR17","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s11096-008-9246-z","volume":"30","author":"ZU Babar","year":"2008","unstructured":"Babar ZU, Jamshed S. Social pharmacy strengthening clinical pharmacy: Why pharmaceutical policy research is needed in Pakistan? Pharm World Sci. 2008;30(5):617\u20139. https:\/\/doi.org\/10.1007\/s11096-008-9246-z.","journal-title":"Pharm World Sci"},{"key":"1765_CR18","doi-asserted-by":"publisher","unstructured":"Scahill S, Atif, M,\u00a0Babar ZUD. Defining pharmacy and its practice: a conceptual model for an international audience.\u00a0Integrat Pharm Res Pract 2017;6:121\u20139. https:\/\/doi.org\/10.2147\/IPRP.S124866.","DOI":"10.2147\/IPRP.S124866"},{"key":"1765_CR19","first-page":"1","volume-title":"Encyclopaedia of pharmacy practice and clinical pharmacy","author":"SS Hasan","year":"2019","unstructured":"Hasan SS, Thiruchelvam K, Kairuz T, et al. Pharmacy practice and its research: evolution and definitions. In: Babar ZUD, editor., et al., Encyclopaedia of pharmacy practice and clinical pharmacy. London Academic Press; 2019. p. 1\u20136."},{"key":"1765_CR20","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s40545-020-00242-2","volume":"13","author":"T Hafner","year":"2020","unstructured":"Hafner T, Banda M, Kohler J, et al. Integrating pharmaceutical systems strengthening in the current global health scenario: three \u201cuncomfortable truths.\u201d J Pharm Policy Pract. 2020;13:38. https:\/\/doi.org\/10.1186\/s40545-020-00242-2.","journal-title":"J Pharm Policy Pract"},{"key":"1765_CR21","unstructured":"Rajan D, Rouleau K, Winkelmann J et al. Implementing the primary health care approach: a primer. PHC Global report. European Observatory on Health Systems and Policies, WHO Headquarters (HQ), 2024. https:\/\/eurohealthobservatory.who.int\/publications\/i\/implementing-the-primary-health-care-approach-a-primer. Accessed 24 May 2024."},{"key":"1765_CR22","doi-asserted-by":"publisher","unstructured":"McLachlan AJ, Aslani P. National medicines policy 2.0-what's changed and what's next? Aust Prescr. 2023;46(4):72\u20134. https:\/\/doi.org\/10.18773\/austprescr.2023.023","DOI":"10.18773\/austprescr.2023.023"},{"key":"1765_CR23","unstructured":"World Health Organisation .How to develop and implement a national drug policy 2nd Edition. 2021. https:\/\/iris.who.int\/bitstream\/handle\/10665\/42423\/924154547X.pdf?sequence=1. Accessed 16 May 2024."},{"key":"1765_CR24","doi-asserted-by":"publisher","DOI":"10.1007\/s11096-024-01733-x","author":"L Karim","year":"2024","unstructured":"Karim L, McIntosh T, Jebara T, et al. Investigating practice integration of independent prescribing by community pharmacists using normalization process theory: a cross-sectional survey. Int J Clin Pharm. 2024. https:\/\/doi.org\/10.1007\/s11096-024-01733-x.","journal-title":"Int J Clin Pharm"},{"issue":"5","key":"1765_CR25","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.sapharm.2024.01.006","volume":"20","author":"RL Walpola","year":"2024","unstructured":"Walpola RL, Issakhany D, Gisev N, et al. The accessibility of pharmacist prescribing and impacts on medicines access: a systematic review. Res Social Adm Pharm. 2024;20(5):475\u201386.","journal-title":"Res Social Adm Pharm"},{"key":"1765_CR26","unstructured":"The FIP Brisbane Calls to Action The consensus from the FIP Workforce Symposium \u201cAccelerating towards 2030: Workforce transformation for better health\u201d Brisbane, Australia, September 2023. https:\/\/www.fip.org\/file\/5644. Accessed 16  May 2024."},{"issue":"1","key":"1765_CR27","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s40545-020-00288-2","volume":"14","author":"ZU Babar","year":"2021","unstructured":"Babar ZU. Ten recommendations to improve pharmacy practice in low and middle-income countries (LMICs). J Pharm Policy Pract. 2021;14(1):6.","journal-title":"J Pharm Policy Pract"},{"key":"1765_CR28","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/1471-2334-10-203","volume":"10","author":"U Hadi","year":"2010","unstructured":"Hadi U, Broek PVD, Kolopaking EP, et al. Cross-sectional study of availability and pharmaceutical quality of antibiotics requested with or without prescription (over the counter) in Surabaya. Indonesia BMC Infect Dis. 2010;10:203.","journal-title":"Indonesia BMC Infect Dis"},{"issue":"1","key":"1765_CR29","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jinf.2018.07.001","volume":"78","author":"A Auta","year":"2019","unstructured":"Auta A, Hadi MA, Oga E, et al. Global access to antibiotics without prescription in community pharmacies: a systematic review and meta-analysis. J Infect. 2019;78(1):8\u201318.","journal-title":"J Infect"},{"key":"1765_CR30","doi-asserted-by":"crossref","unstructured":"Ozawa S, Shankar R, Leopold C, Orubu S. Access to medicines through health systems in low- and middle-income countries. Health Policy Plan. 2019;34(Supplement_3):iii1-iii3.","DOI":"10.1093\/heapol\/czz119"},{"key":"1765_CR31","unstructured":"WHO guideline on country pharmaceutical pricing policies, second edition. Geneva: World Health Organization; 2020. Licence: CC BY\u2010NC\u2010SA 3.0 IGO."},{"issue":"1","key":"1765_CR32","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s40545-022-00413-3","volume":"15","author":"ZU Babar","year":"2022","unstructured":"Babar ZU. Forming a medicines pricing policy for low and middle-income countries (LMICs): the case for Pakistan. J Pharm Policy Pract. 2022;15(1):9.","journal-title":"J Pharm Policy Pract"},{"key":"1765_CR33","volume-title":"The world medicines situation 2011: access to essential medicines as part of the right to health","author":"HV Hogerzeil","year":"2011","unstructured":"Hogerzeil HV, Mirza Z. The world medicines situation 2011: access to essential medicines as part of the right to health. Geneva: World Health Organization; 2011."},{"key":"1765_CR34","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/1471-2261-10-25","volume":"10","author":"MS van Mourik","year":"2010","unstructured":"van Mourik MS, Cameron A, Ewen M, et al. Availability, price and affordability of cardiovascular medicines: a comparison across 36 countries using WHO\/HAI data. BMC Cardiovasc Disord. 2010;10:25.","journal-title":"BMC Cardiovasc Disord"},{"key":"1765_CR35","unstructured":"How does Universal Health Coverage workhttps:\/\/www.commonwealthfund.org\/international-health-policy-center\/system-features\/how-does-universal-health-coverage-work. Accessed 16 May 2024."},{"issue":"1","key":"1765_CR36","first-page":"1","volume":"2","author":"ZU Babar","year":"2009","unstructured":"Babar ZU, Scahill S. Mapping the pharmaceutical situation in your country: first things first. South Med Rev. 2009;2(1):1.","journal-title":"South Med Rev"},{"issue":"3","key":"1765_CR37","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.healthpol.2014.06.004","volume":"117","author":"Z-U-D Babar","year":"2014","unstructured":"Babar Z-U-D, Kan SW, Scahill SL. Interventions promoting the use of generic medicines: a narrative review of the literature. Health Policy. 2014;117(3):285\u201396.","journal-title":"Health Policy"},{"issue":"3","key":"1765_CR38","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1093\/heapol\/czg038","volume":"18","author":"YJ Chou","year":"2003","unstructured":"Chou YJ, Yip WC, Lee CH, et al. Impact of separating drug prescribing and dispensing on provider behaviour: Taiwan\u2019s experience. Health Policy Plan. 2003;18(3):316\u201329.","journal-title":"Health Policy Plan"},{"issue":"3","key":"1765_CR39","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.sapharm.2017.04.005","volume":"14","author":"ZU Babar","year":"2018","unstructured":"Babar ZU, Siraj AM, Curley L. A review of DTCA techniques: appraising their success and potential impact on medication users. Res Social Adm Pharm. 2018;14(3):218\u201327.","journal-title":"Res Social Adm Pharm"},{"issue":"1","key":"1765_CR40","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s40545-023-00626-0","volume":"16","author":"R Hussain","year":"2023","unstructured":"Hussain R, Babar ZU. Global landscape of community pharmacy services remuneration: a narrative synthesis of the literature. J Pharm Policy Pract. 2023;16(1):118.","journal-title":"J Pharm Policy Pract"},{"key":"1765_CR41","unstructured":"Seventh Community Pharmacy Agreement (7CPA), Australian Government Department of Health.https:\/\/www.health.gov.au\/topics\/primary-care\/what-we-do\/7cpa. Accessed 16  May 2024."},{"key":"1765_CR42","unstructured":"Pharmaceutical Management Agency of New Zealand.\u00a0https:\/\/pharmac.govt.nz\/.\u00a0Accessed 16  May 2024."},{"key":"1765_CR43","unstructured":"National Institute for Health and Care Excellence.\u00a0https:\/\/www.nice.org.uk\/.\u00a0Accessed 16 May 2024."},{"issue":"1","key":"1765_CR44","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12961-020-00647-0","volume":"19","author":"M Sharma","year":"2021","unstructured":"Sharma M, Teerawattananon Y, Dabak SV, et al. A landscape analysis of health technology assessment capacity in the Association of South-East Asian Nations region. Health Res Policy Syst. 2021;19(1):19.","journal-title":"Health Res Policy Syst"},{"key":"1765_CR45","unstructured":"Pharmaceutical Services Programme, Ministry of Health Malaysia. (2024). Pharmacy Research Priorities in Malaysia (Second Edition). https:\/\/pharmacy.moh.gov.my\/en\/documents\/pharmacy-research-priorities-malaysia-second-edition.html. Accessed 16 May 2024."},{"key":"1765_CR46","doi-asserted-by":"crossref","unstructured":"Gulpinar F, Pehlivanli A, Babar ZUD. Pharmacy Practice and Policy Research in T\u00fcrkiye: A Review of Literature Between 2019 and 2024 (unpublished draft).","DOI":"10.1080\/20523211.2024.2385939"},{"issue":"3","key":"1765_CR47","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1007\/s11096-014-9933-x","volume":"36","author":"SS Allemann","year":"2014","unstructured":"Allemann SS, van Mil JW, Botermann L, et al. Pharmaceutical care: the PCNE definition 2013. Int J Clin Pharm. 2014;36(3):544\u201355.","journal-title":"Int J Clin Pharm"}],"container-title":["International Journal of Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-024-01765-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11096-024-01765-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-024-01765-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T04:51:38Z","timestamp":1726203098000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11096-024-01765-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,19]]},"references-count":47,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["1765"],"URL":"https:\/\/doi.org\/10.1007\/s11096-024-01765-3","relation":{},"ISSN":["2210-7703","2210-7711"],"issn-type":[{"value":"2210-7703","type":"print"},{"value":"2210-7711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,19]]},"assertion":[{"value":"14 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The author has no conflicts of interest to declare.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}